Skip to Main Content

Paper Details

C25-modified rifamycin derivatives with improved activity against <i>Mycobacterium abscessus</i>.
PNAS Nexus
5
2022
Author NameAffiliation
Bree B AldridgeTufts University School of Medicine and Stuart B. Levy Center for Integrated Management of Antimicrobial Resistance
  • 1 - 1

Datasets

Release 1.2